Decoy Therapeutics Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Decoy Therapeutics Inc. (DCOY) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $700.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-12
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $700.00K.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $900.00K.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.10M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $30.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed |
|---|---|---|
| 2026-06-30 | $700.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $900.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.10M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $30.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $100.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $100.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $300.00K 10-K · filed 2025-03-21 | |
| 2023-09-30 | $400.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $600.00K 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $700.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $800.00K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $1.00M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.20M 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-11 | $1.30M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $900.00K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $1.00M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $1.10M 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $1.30M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $1.30M 10-K · filed 2022-03-25 | $1.34M 10-K · filed 2021-03-18 |
| 2020-09-30 | $400.00K 10-Q · filed 2021-11-04 | $358.87K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $400.00K 10-Q · filed 2021-08-05 | $395.61K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $500.00K 10-Q · filed 2021-05-12 | $489.64K 10-Q/A · filed 2020-05-15 |
| 2019-12-31 | $500.00K 10-K · filed 2021-03-18 | $493.36K 10-K · filed 2020-03-23 |
| 2019-09-30 | $610.11K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.73M 10-Q · filed 2019-07-17 | |
| 2019-03-31 | $1.94M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $2.16M 10-K · filed 2019-03-06 | |
| 2018-09-30 | $2.48M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $2.98M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $5.01M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $4.53M 10-K · filed 2018-03-07 | |
| 2017-09-30 | $5.80M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $7.13M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $8.63M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $8.67M 10-K · filed 2017-03-08 | |
| 2016-09-30 | $14.47M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $13.81M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $15.75M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $15.50M 10-K · filed 2016-03-08 | |
| 2015-09-30 | $14.39M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $20.33M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $21.95M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $12.63M 10-K · filed 2015-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |